
Germany's beleaguered state railway operator Deutsche Bahn said Friday its losses widened last year and warned passengers to brace for less-than-perfect service for years to come.
Deutsche Bahn lost 2.3 billion euros ($2.6 billion) in 2025, compared to a loss of 1.8 billion euros a year earlier, hit by a 1.4-billion euro blow to the value of the long-distance division, DB Fernvekhr.
In bad news for long-suffering passengers, DB head Evelyn Palla told a press conference that the write-off resulted from expectations of a poor service stretching into the future.
"We have reassessed our future revenue forecasts, basing them on the actual state of our infrastructure," she said. "And this remains inadequate."
Long derided at home, DB made headlines abroad during the 2024 European Football Championships after fans and even players arrived at destinations hours later than planned.
Almost 40 percent of long-distance services arrived late last year -- not including trains that were cancelled, which are not counted in punctuality statistics.
Germany's government has promised to borrow and spend billions on renewing the network.
But Transport Minister Patrick Schnieder in September pushed back a punctuality target of 70 percent for long-distance trains to 2029 from 2026.
Speaking on Friday, Palla said it would take time for the railway to improve both its financial performance and its service.
"There is a long way ahead of us," she said. "It will take at least 10 years to get German railways back into good shape. We need to recognise this reality and put it into our numbers."
Though fully-owned by the government, DB is nevertheless under pressure to boost profitability.
DB Cargo, its loss-making freight arm, is facing an EU investigation under state aid rules and the firm said in February it would cut about 6,000 jobs in Germany, equivalent to half its domestic workforce.
Without the write-off, DB's operating profit improved by over 600 million euros to 297 million euros after an operating loss in 2024.
vbw/fz/gv
LATEST POSTS
- 1
Corcept Therapeutics shares surge as lead drug gets FDA nod for ovarian cancer - 2
Addiction-stricken community struggles to keep a syringe program going after Trump's order - 3
Indian rocket launches record-breaking BlueBird 6 smartphone satellite to orbit (video) - 4
Explosions at Burundi ammunition depot kill civilians, witnesses say - 5
Mexican Woman Accused of Assaulting Partner With Belt After He Refused Sex, Police Say
Linda Hamilton, 69, says she doesn't want to 'chase longevity'
Vote In favor of Your Favored Kind Of Organic product
How Trump's marijuana executive order could change medical research landscape
FDA official discusses potential link between COVID-19 vaccines and pediatric deaths
'All's Fair,' Ryan Murphy's new show starring Kim Kardashian, hit with scathing reviews: 'A girlboss fever dream'
Remote Headphones: Improve Your Sound Insight
19 Strange Motion pictures You Shouldn't Watch With Your Mum
Vote In favor of Your #1 Electric Vehicles
Dozens injured in Russia after train crashes, overturns












